The perfusion index is a useful screening tool for peripheral artery disease.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 28 05 2018
accepted: 28 09 2018
pubmed: 5 10 2018
medline: 18 5 2019
entrez: 5 10 2018
Statut: ppublish

Résumé

The number of people with peripheral artery disease (PAD) has been increasing globally; therefore, it is important to explore more options to screen patients who are at a risk of developing PAD. The perfusion index (PI) represents the degree of circulation through the peripheral tissues and is measured noninvasively. We investigated the correlation between the PI and ankle-brachial index (ABI) to explore whether the PI could be used a screening tool for PAD. This cross-sectional study included 390 patients. We measured the ABI and PI for all patients. The median ABI value was 1.06 (0.92-1.13); the PI was 1.7% (0.9-3.5). The PI was higher in men than in women (P < 0.0001). The PI was positively correlated with the estimated glomerular filtration rate and ABI in both men and women. The sensitivity and specificity of the PI to predict PAD (ABI ≤0.9) were 90.0% and 80.3%, respectively, and the cutoff PI value was 1.5% in men. The sensitivity and specificity of the PI to predict PAD were 82.1% and 79.2%, respectively, and the cutoff PI value was 1.1% in women. PI could be a reliable screening tool for diagnosing PAD because it does not restrict the patient's mobility, can be completed in a short time period, and is associated with reduced costs.

Identifiants

pubmed: 30284017
doi: 10.1007/s00380-018-1276-4
pii: 10.1007/s00380-018-1276-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

583-589

Références

Crit Care Med. 2002 Jun;30(6):1210-3
pubmed: 12072670
Hypertens Res. 2016 Dec;39(12):868-873
pubmed: 27412797
Circulation. 2017 Mar 21;135(12):e686-e725
pubmed: 27840332
Circulation. 1995 Mar 1;91(5):1472-9
pubmed: 7867189
Circ J. 2007 Jul;71(7):995-1003
pubmed: 17587702
Jpn Circ J. 2000 Dec;64(12):925-7
pubmed: 11194284
Diabetes Care. 2003 Jan;26 Suppl 1:S5-20
pubmed: 12502614
Surgery. 1975 Dec;78(6):795-9
pubmed: 1188622
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
N Engl J Med. 1992 Feb 6;326(6):381-6
pubmed: 1729621
JAMA. 2001 Sep 19;286(11):1317-24
pubmed: 11560536
Semin Vasc Surg. 1999 Jun;12(2):142-7
pubmed: 10777241
Circulation. 1985 Mar;71(3):510-5
pubmed: 3156006
Vet Anaesth Analg. 2013 Mar;40(2):149-56
pubmed: 22978823
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Diabetes Care. 2009 Apr;32(4):e44
pubmed: 19336632
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
Circulation. 2009 Nov 24;120(21):2053-61
pubmed: 19901192
BMC Fam Pract. 2014 Apr 17;15:69
pubmed: 24742018
Hypertens Res. 2002 May;25(3):359-64
pubmed: 12135313
Eur Rev Med Pharmacol Sci. 2018 May;22(10):3160-3165
pubmed: 29863271

Auteurs

Hiroshi Okada (H)

Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, 5-55 Sotojima-cho, Moriguchi, 570-8540, Japan. conti@koto.kpu-m.ac.jp.

Muhei Tanaka (M)

Department of Internal Medicine, Kyotamba Hospital, Kyotamba, Japan.

Takashi Yasuda (T)

Department of Nephrology, Matsushita Memorial Hospital, Moriguchi, Japan.

Tadaaki Kamitani (T)

Department of Cardiology, Matsushita Memorial Hospital, Moriguchi, Japan.

Hisahiro Norikae (H)

Department of General Affairs, Matsushita Memorial Hospital, Moriguchi, Japan.

Tetsuya Fujita (T)

Department of General Affairs, Matsushita Memorial Hospital, Moriguchi, Japan.

Takashi Nishi (T)

Department of General Affairs, Matsushita Memorial Hospital, Moriguchi, Japan.

Hirokazu Oyamada (H)

Department of Gastroenterology, Matsushita Memorial Hospital, Moriguchi, Japan.

Tetsuro Yamane (T)

Department of Surgery, Matsushita Memorial Hospital, Moriguchi, Japan.

Michiaki Fukui (M)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH